docetaxel anhydrous has been researched along with somatostatin in 1 studies
| Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (somatostatin) | Trials (somatostatin) | Recent Studies (post-2010) (somatostatin) |
|---|---|---|---|---|---|
| 12,110 | 3,216 | 6,920 | 29 | 0 | 11 |
| Protein | Taxonomy | docetaxel anhydrous (IC50) | somatostatin (IC50) |
|---|---|---|---|
| Somatostatin receptor type 5 | Mus musculus (house mouse) | 0.0001 | |
| Protein-lysine 6-oxidase | Homo sapiens (human) | 0.01 | |
| Somatostatin receptor type 1 | Homo sapiens (human) | 0.0012 | |
| Somatostatin receptor type 1 | Mus musculus (house mouse) | 0.0001 | |
| Somatostatin receptor type 2 | Homo sapiens (human) | 0.0007 | |
| Somatostatin receptor type 2 | Mus musculus (house mouse) | 0.0002 | |
| Somatostatin receptor type 3 | Mus musculus (house mouse) | 0.0001 | |
| Somatostatin receptor type 5 | Rattus norvegicus (Norway rat) | 0.0009 | |
| Somatostatin receptor type 4 | Homo sapiens (human) | 0.0012 | |
| Somatostatin receptor type 3 | Homo sapiens (human) | 0.002 | |
| Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 2 | |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 0.006 | |
| Somatostatin receptor type 5 | Homo sapiens (human) | 0.003 | |
| Somatostatin receptor type 4 | Mus musculus (house mouse) | 0.0001 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
1 other study(ies) available for docetaxel anhydrous and somatostatin
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |